MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Nantes University Hospital
Masonic Cancer Center, University of Minnesota
Institute of Hematology and Blood Transfusion, Czech Republic
Orca Biosystems, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
BeOne Medicines
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Mayo Clinic
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Chordia Therapeutics, Inc.
University of Alabama at Birmingham
GluBio Therapeutics Inc.
National Cancer Institute (NCI)
Beijing InnoCare Pharma Tech Co., Ltd.
PedAL BCU, LLC
Stanford University
TScan Therapeutics, Inc.
Bristol-Myers Squibb
Seagen Inc.
Dana-Farber Cancer Institute
Taiho Oncology, Inc.
University of Rochester
Mayo Clinic
National Institutes of Health Clinical Center (CC)
University of Southern California
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Kansas Medical Center
Remedy Plan, Inc.
Sumitomo Pharma America, Inc.
Dana-Farber Cancer Institute